These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oxidative stress, microvascular dysfunction, and scleroderma: an association with potential therapeutic implications, a commentary on "Postocclusive reactive hyperemia inversely correlates with urinary 15-F2t-isoprostane levels in systemic sclerosis". Chung CP; Avalos I; Stein CM Free Radic Biol Med; 2006 May; 40(10):1698-9. PubMed ID: 16678008 [No Abstract] [Full Text] [Related]
6. Prescleroderma: a distinct stage of systemic sclerosis. Amato L; Gallerani I; Berti S; Fabbri P Skinmed; 2003; 2(1):59-61. PubMed ID: 14673329 [No Abstract] [Full Text] [Related]
7. [Scleroderma microangiopathy. Physiopathogenic hypothesis]. Fiessinger JN; Cailleri JP; Mignot J; Kazandjian S; Vayssairat M; Housset E Rev Med Interne; 1980; 1(1):61-4. PubMed ID: 7232908 [No Abstract] [Full Text] [Related]
8. [Peripheral vascular syndrome in scleroderma in children]. Shliapak EA Pediatriia; 1979 Sep; (9):53-5. PubMed ID: 492861 [No Abstract] [Full Text] [Related]
9. The differential diagnosis of Raynaud's phenomenon. Wigley FM Hosp Pract (Off Ed); 1991 Jul; 26(7):63-70, 73-84. PubMed ID: 2071684 [No Abstract] [Full Text] [Related]
10. The vasculopathy of Raynaud's phenomenon and scleroderma. Flavahan NA; Flavahan S; Mitra S; Chotani MA Rheum Dis Clin North Am; 2003 May; 29(2):275-91, vi. PubMed ID: 12841295 [TBL] [Abstract][Full Text] [Related]
11. Influence of bosentan on fingertip rewarming in patients with systemic sclerosis. Autenrieth J; Riemekasten G; Bert C; Worm M J Dtsch Dermatol Ges; 2013 Apr; 11(4):356-9. PubMed ID: 23419126 [No Abstract] [Full Text] [Related]
12. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Maricq HR; Spencer-Green G; LeRoy EC Am J Med; 1976 Dec; 61(6):862-70. PubMed ID: 1008072 [TBL] [Abstract][Full Text] [Related]
13. Studies in patients with connective tissue disorders. Maricq HR; Gordon G; Leroy EC Bibl Anat; 1977; (16 Pt 2):135-41. PubMed ID: 603498 [No Abstract] [Full Text] [Related]
14. Iontophoretic evaluation of vascular reactivity to acetylcholine in patients with primary Raynaud's phenomenon and systemic sclerosis. Marasini B; Conciato L Clin Rheumatol; 2001; 20(6):451-2. PubMed ID: 11771535 [No Abstract] [Full Text] [Related]
15. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study. Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479 [TBL] [Abstract][Full Text] [Related]
16. Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study. Cutolo M; Ferrone C; Pizzorni C; Soldano S; Seriolo B; Sulli A J Rheumatol; 2010 Jun; 37(6):1174-80. PubMed ID: 20436070 [TBL] [Abstract][Full Text] [Related]
17. [Capillary microscopy of the nail fold in Raynaud's phenomenon. Use in the early diagnosis of scleroderma]. Rivera Redondo J; López Bote JP; Alvaro-Gracia Alvaro JM; Sabando Suárez P; Ossorio Castellanos C Rev Clin Esp; 1985 Jun; 177(1):7-10. PubMed ID: 4035042 [No Abstract] [Full Text] [Related]
18. Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis. Gaillard-Bigot F; Roustit M; Blaise S; Gabin M; Cracowski C; Seinturier C; Imbert B; Carpentier P; Cracowski JL Microvasc Res; 2014 Jul; 94():90-5. PubMed ID: 24990822 [TBL] [Abstract][Full Text] [Related]
19. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma. Maricq HR Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525 [TBL] [Abstract][Full Text] [Related]